Latest Biotechnology, Pharmaceutical and Healthcare News from PharmaBiz

00:39 EDT 23rd June 2018 | BioPortfolio

Here are the most relevant search results for "PharmaBiz" found in our extensive news archives from over 250 global news sources.

More Information about PharmaBiz on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PharmaBiz for you to read. Along with our medical data and news we also list PharmaBiz Clinical Trials, which are updated daily. BioPortfolio also has a large database of PharmaBiz Companies for you to search.

Showing News Articles 1–25 of 545 from PharmaBiz

Friday 22nd June 2018

Roche appoints James Sabry as global head of partnering

Roche announced that Sophie Kornowski─Bonnet, head of Roche Partnering and member of the enlarged corporate executive committee since 2012, has accepted a new opportunity and will be leaving the

Alligator Bioscience presents positive additional preclinical data from ATOR─1017 to treat metastasizing cancer at WPC meeting

Alligator Bioscience, a biotechnology company developing antibody─based pharmaceuticals for tumour─directed immunotherapy, has presented additional preclinical data for the drug candidate ATOR─1017 at the 3rd

TG Therapeutics, Novimmune ink agreement to develop and commercialize novel anti─CD47/anti─CD19 bispecific antibody

TG Therapeutics, Inc and Novimmune SA, announced that the companies have entered into an exclusive global agreement to collaborate on the development and commercialization of Novimmune's novel first─in─class

SKCDA seeks more clarification from DCGI on separate shelf for generic medicines in retail shops

The Suvarna Karnataka Chemists and Distributors Association (SKCDA) has sought more information and clarification from the Drug Controller General of India (DCGI) on the issue of providing a separate shelf or rack

Thursday 21st June 2018

Pacira grants Nuance Biotech exclusive rights to develop & commercialize Exparel in China

Pacira Pharmaceuticals, Inc and Nuance Biotech Co. Ltd have entered into an agreement to advance the development and commercialization of Exparel (bupivacaine liposome injectable suspension) in China. Exparel is

Natera, Institut Jules Bordet ink neoadjuvant breast cancer research collaboration

Natera, Inc, a global leader in cell─free DNA testing, has announced a research collaboration with the Institut Jules Bordet, an internationally renowned multidisciplinary cancer reference center in Belgium, using the

Supply Of Medicine. 1) Lotion Calamine

Supply Of Medicine. 1) Lotion Calamine

NIH funded study finds methadone and buprenorphine reduce risk of death after opioid overdose

A National Institutes of Health (NIH)─funded study found that treatment of opioid use disorder with either methadone or buprenorphine following a nonfatal opioid overdose is associated with significant reductions in opioid related mortality.

EMA & European Commission update guidance for pharma companies to prepare for UK's withdrawal from EU

The European Medicines Agency (EMA) and the European Commission have updated their guidance to help pharmaceutical companies prepare for the United Kingdom's (UK) withdrawal from the European Union (EU).

Shortage of ophthalmologists & inadequate nutrition prime reasons for rise in cataracts: Dr. Sridhar Prasad

India is manifesting a rise in cataracts primarily because of a dearth of ophthalmologists and not enough nourishment among its population, said Dr. Sridhar Prasad, senior manager, applications – LenSx, Alcon India.

Wednesday 20th June 2018

Mundipharma launches Zubsolv in EU, Orexo to get EUR 3 million milestone payment

Orexo AB announces that its partner Mundipharma has initiated the launch of Zubsolv (buprenorphine and naloxone sublingual tablet), for use in the treatment of opioid dependence, in the EU.

Sanofi appoints Jean─Baptiste Chasseloup de Chatillon as executive VP, CFO

Sanofi has appointed Jean─Baptiste Chasseloup de Chatillon as executive vice president, chief financial officer (CFO) and member of the executive committee, effective October 1st 2018. He will join Sanofi September 1st

Alchem receives European Certificate of Suitability for innovative production process to resolve stability challenge for micronized digoxin

Alchem International Private Limited, a privately held pharmaceutical company focusing on the production of plant derived active pharmaceutical ingredients, has announced the award of European Certificate of Suitability

Healthcare sector – treading a higher M&A curve

The Indian healthcare sector is expected to expand at an exponential pace and is widely anticipated to clock revenues of around US$ 280 billion by 2020.


The Indian government's unending search for an alternative to end the over─dependence of Indian pharmaceutical companies on China for APIs has come a full circle as the Union Chemicals Ministry has proposed to

J&J Vision's next generation of customized LASIK treatment, iDESIGN refractive studio gets US FDA approval

Johnson & Johnson Vision announced the US Food and Drug Administration (FDA) approval of the iDESIGN refractive studio, making it the only system to use topography─integrated, wavefront─guided technology.

Boehringer Ingelheim expands European Metacam indication to guinea pigs

Boehringer Ingelheim adds a new species to its Metacam (active ingredient: meloxicam) brand in Europe, expanding the indications of this widely used analgesic and anti─inflammatory medicine to guinea pigs.

Diabetics a rising healthcare challenge for India, needs to be tackled with early intervention: Experts

Expressing their concern over the menace of ever rising cases of diabetes, healthcare experts felt that it has become a contemporary healthcare challenge which needs to be nipped in the bud rather than crying foul at the later stage, when it reaches epidemic proportions.

Tuesday 19th June 2018

NeuroVive out─licenses targeted LHON therapy to BridgeBio Pharma

NeuroVive Pharmaceutical AB and BridgeBio Pharma jointly announced that BridgeBio has entered into an exclusive licensing agreement for a subset of succinate prodrug chemistry under NeuroVive's NVP015

ZEISS introduces next generation of ophthalmic laser VISULAS green to treat variety of eye diseases

The medical technology business group of ZEISS unveiled its next─generation VISULAS green photocoagulation laser at the world ophthalmology congress in Barcelona. Retinal photocoagulation lasers are used

Alcon AcrySof IQ PanOptix IOL shows superior visual performance in head─to─head trial post─cataract surgery

Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the AcrySof IQ PanOptix intraocular lens (IOL) compared to

Jan Aushadhi generic medical shops should be run by Red Cross volunteers: Governor Narasimhan

E S L Narasimhan, Governor of Andhra Pradesh and Telangana State, has urged the Red Cross Society to take over all the Jan Aushadhi Generic Medical shops run under the national programme at government hospitals

Monday 18th June 2018

Teva updates ENFORCE phase III clinical trial of fremanezumab for use in chronic cluster headache

Teva Pharmaceutical Industries Ltd has announced a change in the clinical development programme of fremanezumab in chronic cluster headache. The ENFORCE phase III clinical development programme includes a

ceiling Price of scheduled medicines fixed/revised under DPCO, 2013: YEAR : 2014

ceiling Price of scheduled medicines fixed/revised under DPCO, 2013: YEAR : 2014

PHARMA PATENTS GRANTED DURING 2010─11 TO 2013─14 ( UP TO 31─7─2013)

PHARMA PATENTS GRANTED DURING 2010─11 TO 2013─14 ( UP TO 31─7─2013)

Quick Search


News Quicklinks